In this episode of the NET Podcast, Dr. Arshad meets with Dr. Soares, Dr. Shaheen, and Dr. Sonbol at the Tucson Regional Conference to discuss the evolving landscape of neuroendocrine tumors, focusing on recent studies such as the COMPETE study and the implications for treatment sequencing and patient care. They explore the importance of individualized treatment plans, the role of new therapies like cabozantinib, and the real-world challenges faced by patients, including financial toxicity. The conversation highlights the need for ongoing research and collaboration in the field.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Ver todos los episodios